This series examines Nd-YAG laser treatment's efficacy for reducing xanthelasma lesions in a patient cohort, indicating promising outcomes.
Xanthelasma palpebrarum (XP) is a common disorder symmetrically involving the eyelids, caused by the deposition of esterified cholesterol in the dermis. In this series of cases, we observed the efficacy of Q-switched Neodymium-doped Yttrium Aluminum Garnet (Nd-YAG) LASER in xanthelasma. We used a Q-switched Nd-YAG LASER at a fluence of 2 J/cm 2 and a spot size of 2 mm till bleeding spots were seen. The results were evaluated after 4 weeks independently by two blinded dermatologists, and the decrease in size was graded from 0 to 5. A patient’s assessment score was also added (0–5). The series included 13 patients with 38 lesions, and at the end of 4 weeks, improvement was seen in all patients. Six patients showed 50%–75% improvement, and seven patients showed 25%–50% improvement. A few cases showed mild erythema, which resolved on its own on the same day. Thus, Nd-YAG LASER is a valid treatment option for XP with good efficacy and minimal side effects.
No takes yet. Share an insight, caveat, or question.
Nayak et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: